1. Scrip

Quick Fire Q&A: How Is Roche Future-Proofing Its Pipeline?

 
• By Lucie Ellis-Taitt

Lesley Bester, global business development officer for infectious diseases at Roche Holdings and global spokesperson, Anja von Treskow, answered a speed round of eight questions during the BIO-Europe Spring partnering conference, held in Stockholm, Sweden, about how the big pharma incorporates external innovation into its business model and methods the company has for future-proofing its pipeline.

Lesley Bester, global business development officer for infectious diseases at Roche Holdings and global spokesperson, Anja von Treskow, answered a speed round of eight questions during the BIO-Europe Spring partnering conference, held in Stockholm, Sweden, about how the big pharma incorporates external innovation into its business model and methods the company has for future-proofing its pipeline.

1. What recent developments in the infectious disease field at Roche would you highlight?

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Anti-infective

More from Therapy Areas

Replimune CRL Could Hold Warning For Accelerated Approvals

 
• By Jessica Merrill

FDA issued a complete response letter to Replimune’s BLA for a novel oncolytic immunotherapy for melanoma in a surprise to management and investors.

Sanofi Doubles Down On Respiratory Vaccines With Vicebio Buy

 
• By Kevin Grogan

The French major is paying $1.15bn For the UK biotech and its bivalent candidate, VXB-241.

Alkermes To Advance Alixorexton After Positive Phase II Narcolepsy Results

 
• By Alaric DeArment

The biotech company is planning for Phase III based on positive topline results from Vibrance-1 in narcolepsy type 1 and remains optimistic about type 2 disease.